VIDA VENTURES MANAGEMENT
VIDA VENTURES MANAGEMENT is a Pre-seed, Seed, Series A, Series B and Series C+ fund in the US writing $100K–$10M checks into Healthcare, healthcare-tech and pharma-tech.
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+
- Sectors
- Healthcare, healthcare-tech, pharma-tech
- Check size
- $100K–$10M
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2017
- Assets under management
- $1.8B
- Website
- vidaventures.com
Thesis
VIDA Ventures Management is a life sciences investment firm founded in 2017, dedicated to advancing transformative biomedical innovations. With approximately $1.8 billion in AUM, the firm focuses on sectors such as biotech, healthcare, and pharma-tech, primarily within the United States. VIDA Ventures invests across stages from friends & family to growth equity, targeting companies with innovative approaches in areas like oncology, immunology, CAR-T, radiopharmaceuticals, precision medicine, autoimmune diseases, genetic medicines, and neurodegeneration. The firm's strategy involves translating these innovations into therapies through equity capital investments. VIDA Ventures III has a fund size of $600 million, and Vida Ventures II also has a fund size of $600 million.
Common questions
Does VIDA VENTURES MANAGEMENT invest at the Pre-seed stage?
Yes. VIDA VENTURES MANAGEMENT lists Pre-seed, Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does VIDA VENTURES MANAGEMENT write?
VIDA VENTURES MANAGEMENT writes $100K–$10M checks.
Where does VIDA VENTURES MANAGEMENT invest?
VIDA VENTURES MANAGEMENT invests in the US.